Osteoporosis Trial, Recruiting NCT05266976 Sponsor: VA Office of Research and Development Condition: Osteoporosis
Back to Osteoporosis

Osteoporosis Trial, Recruiting

NCT05266976
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • People aged 60 or older who are veterans
  • People who live in the Denver Metro Area
  • People who are generally active, such as those who regularly walk or cycle for recreation

Who may not be able to join:

  • People whose kidneys are not functioning well enough (based on a blood test result called eGFR being below a certain level)
  • People with liver or gallbladder disease (based on liver blood test results being too high)
  • People with a thyroid condition where thyroid hormone levels fall outside a specific range
  • People with calcium levels in the blood that are too low or too high
  • People with low vitamin D levels in the blood
  • People with uncontrolled high blood pressure, where resting blood pressure readings are above a certain level
  • People with a history of type 1 or type 2 diabetes
  • People with heart disease, including signs of reduced blood flow to the heart or serious irregular heart rhythms, either at rest or during a supervised exercise test (note: people with an uncertain exercise test result may be reconsidered after further heart testing reviewed by a heart specialist)
  • People with low red blood cell levels (anaemia), based on blood test results falling below a set level for women or men
  • People who have had a bone fracture in the past 6 months
  • People who currently have COVID-19 or are experiencing COVID-19 symptoms (people who have recovered and have been cleared to return to exercise by their doctor may be eligible to participate)

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 28 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Sarah J Wherry, PhD, Rocky Mountain Regional VA Medical Center, Aurora, CO

Phone: (720) 848-6475

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Registry
ClinicalTrials.gov
Start date
6 July 2022
Est. completion
31 March 2027

Where this trial is recruiting

🇺🇸 United States

Primary endpoints

c-telopeptide of type 1 collagen (CTX) change; Procollagen 1 intact N-terminal propeptide (P1NP); Short Physical Performance Battery (SPPB); 6-minute walk test

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 28 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov